Trial · NCT02263638
Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study
NCT02263638, Phase 2, Terminated, Rennes University Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study. Trials, record NCT02263638. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02263638
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study
- NCT number
- NCT02263638
- Status
- Terminated
- Phases
- Phase 2
- Enrollment
- 17 participants, actual
- Lead sponsor
- Rennes University Hospital
- Conditions
- Refractory Hemochromatosis Rheumatism
- Interventions
- Anakinra
- First posted
- 2014-10-13
- Last updated
- 2019-03-12
Source ClinicalTrials.gov
Registered outcomes23
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Rate of patients with improvement of joint pain | Day 15 | Improvement is defined as the minimal clinically important improvement of joint pain and is assessed on a 0-100 mm visual analogue scale (VAS) |
| Secondary | Assessment of the disease activity | Day 0, day 15, day 30, day 60, day 90 | Assessment of the disease activity by Visual analog scale (VAS) |
| Secondary | Assessment of the number of painful joints | Day 0, day 15, day 30, day 60, day 90 | Assessment of the number of painful joints by a clinical exam |
| Secondary | Assessment of the number of swollen joints | Day 0, day 15, day 30, day 60, day 90 | Assessment of the number of swollen joints by a clinical exam |
| Secondary | Assessment of analgesics consumption | Day 0, day 15, day 30, day 60, day 90 | |
| Secondary | Assessment of non-steroidal anti-inflammatory drugs (NSAID) consumption | Day 0, day 15, day 30, day 60, day 90 | |
| Secondary | Assessment of colchicine consumption | Day 0, day 15, day 30, day 60, day 90 | |
| Secondary | Assessment of steroids injections consumption | Day 0, day 15, day 30, day 60, day 90 | |
| Secondary | Assessment of the quality of life | Day 0, day 15, day 30, day 90 | Assessment of the quality of life by the SF36 questionnaire |
| Secondary | Assessment of the quality of life | Day 0, day 15, day 30, day 90 | Assessment of the quality of life by the HAQ questionnaire |
1 to 10 of 23Source ClinicalTrials.gov
See all 23 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02263638
GET https://conductscience.org/api/trials/v1/NCT02263638/registered?page=2